These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 36252893)

  • 1. Nasopharyngeal microbiome of COVID-19 patients revealed a distinct bacterial profile in deceased and recovered individuals.
    Kumar D; Pandit R; Sharma S; Raval J; Patel Z; Joshi M; Joshi CG
    Microb Pathog; 2022 Dec; 173(Pt A):105829. PubMed ID: 36252893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 infection reduces human nasopharyngeal commensal microbiome with inclusion of pathobionts.
    Hoque MN; Sarkar MMH; Rahman MS; Akter S; Banu TA; Goswami B; Jahan I; Hossain MS; Shamsuzzaman AKM; Nafisa T; Molla MMA; Yeasmin M; Ghosh AK; Osman E; Alam SKS; Uzzaman MS; Habib MA; Mahmud ASM; Crandall KA; Islam T; Khan MS
    Sci Rep; 2021 Dec; 11(1):24042. PubMed ID: 34911967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metagenomic next-generation sequencing of nasopharyngeal microbiota in COVID-19 patients with different disease severities.
    Aljabr W; Dandachi I; Abbas B; Karkashan A; Al-Amari A; AlShahrani D
    Microbiol Spectr; 2024 May; 12(5):e0416623. PubMed ID: 38557102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-Related Changes in the Nasopharyngeal Microbiome Are Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Symptoms Among Children, Adolescents, and Young Adults.
    Hurst JH; McCumber AW; Aquino JN; Rodriguez J; Heston SM; Lugo DJ; Rotta AT; Turner NA; Pfeiffer TS; Gurley TC; Moody MA; Denny TN; Rawls JF; Clark JS; Woods CW; Kelly MS
    Clin Infect Dis; 2022 Aug; 75(1):e928-e937. PubMed ID: 35247047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signatures of COVID-19 Severity and Immune Response in the Respiratory Tract Microbiome.
    Merenstein C; Liang G; Whiteside SA; Cobián-Güemes AG; Merlino MS; Taylor LJ; Glascock A; Bittinger K; Tanes C; Graham-Wooten J; Khatib LA; Fitzgerald AS; Reddy S; Baxter AE; Giles JR; Oldridge DA; Meyer NJ; Wherry EJ; McGinniss JE; Bushman FD; Collman RG
    mBio; 2021 Aug; 12(4):e0177721. PubMed ID: 34399607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring nasopharyngeal microbiota profile in children affected by SARS-CoV-2 infection.
    Romani L; Del Chierico F; Pane S; Ristori MV; Pirona I; Guarrasi V; Cotugno N; Bernardi S; Lancella L; Perno CF; Rossi P; Villani A; Campana A; Palma P; Putignani L;
    Microbiol Spectr; 2024 Mar; 12(3):e0300923. PubMed ID: 38289047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NGS analysis of nasopharyngeal microbiota in SARS-CoV-2 positive patients during the first year of the pandemic in the Campania Region of Italy.
    Giugliano R; Sellitto A; Ferravante C; Rocco T; D'Agostino Y; Alexandrova E; Lamberti J; Palumbo D; Galdiero M; Vaccaro E; Pagliano P; Weisz A; Giurato G; Franci G; Rizzo F
    Microb Pathog; 2022 Apr; 165():105506. PubMed ID: 35358660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to
    Nardelli C; Gentile I; Setaro M; Di Domenico C; Pinchera B; Buonomo AR; Zappulo E; Scotto R; Scaglione GL; Castaldo G; Capoluongo E
    Front Cell Infect Microbiol; 2021; 11():625581. PubMed ID: 33659220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 Infection is Associated with Age- and Gender-Specific Changes in the Nasopharyngeal Microbiome.
    Bozza S; Nunzi E; Frias-Mazuecos A; Pieraccini G; Pariano M; Renga G; Mencacci A; Talesa VN; Antognelli C; Puccetti P; Romani L; Costantini C
    Front Biosci (Landmark Ed); 2024 Feb; 29(2):59. PubMed ID: 38420819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort.
    Newsome RC; Gauthier J; Hernandez MC; Abraham GE; Robinson TO; Williams HB; Sloan M; Owings A; Laird H; Christian T; Pride Y; Wilson KJ; Hasan M; Parker A; Senitko M; Glover SC; Gharaibeh RZ; Jobin C
    Gut Microbes; 2021; 13(1):1-15. PubMed ID: 34100340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in the nasopharyngeal microbiome associated with SARS-CoV-2 infection status and disease severity.
    Gauthier NPG; Locher K; MacDonald C; Chorlton SD; Charles M; Manges AR
    PLoS One; 2022; 17(10):e0275815. PubMed ID: 36240246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Super Dominant Pathobiontic Bacteria in the Nasopharyngeal Microbiota Cause Secondary Bacterial Infection in COVID-19 Patients.
    Qin T; Wang Y; Deng J; Xu B; Zhu X; Wang J; Zhou H; Zhao N; Jin F; Ren H; Wang H; Li Q; Xu X; Guo Y; Li R; Xiong Y; Wang X; Guo J; Zheng H; Hou X; Wan K; Zhang J; Lu J; Kan B; Xu J
    Microbiol Spectr; 2022 Jun; 10(3):e0195621. PubMed ID: 35579467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptome analysis reveals increased abundance and diversity of opportunistic fungal pathogens in nasopharyngeal tract of COVID-19 patients.
    Hoque MN; Rahman MS; Sarkar MMH; Habib MA; Akter S; Banu TA; Goswami B; Jahan I; Hossain MA; Khan MS; Islam T
    PLoS One; 2023; 18(1):e0278134. PubMed ID: 36656835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of COVID-19 Lockdown on the Nasopharyngeal Microbiota of Children and Adults Self-Confined at Home.
    Rocafort M; Henares D; Brotons P; Launes C; Fernandez de Sevilla M; Fumado V; Barrabeig I; Arias S; Redin A; Ponomarenko J; Mele M; Millat-Martinez P; Claverol J; Balanza N; Mira A; Garcia-Garcia JJ; Bassat Q; Jordan I; Muñoz-Almagro C
    Viruses; 2022 Jul; 14(7):. PubMed ID: 35891502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasopharyngeal microbiome reveals the prevalence of opportunistic pathogens in SARS-CoV-2 infected individuals and their association with host types.
    Gupta A; Karyakarte R; Joshi S; Das R; Jani K; Shouche Y; Sharma A
    Microbes Infect; 2022 Feb; 24(1):104880. PubMed ID: 34425246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The salivary and nasopharyngeal microbiomes are associated with SARS-CoV-2 infection and disease severity.
    Kim JG; Zhang A; Rauseo AM; Goss CW; Mudd PA; O'Halloran JA; Wang L
    J Med Virol; 2023 Feb; 95(2):e28445. PubMed ID: 36583481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral dysbiosis and its linkage with SARS-CoV-2 infection.
    Gupta A; Bhanushali S; Sanap A; Shekatkar M; Kharat A; Raut C; Bhonde R; Shouche Y; Kheur S; Sharma A
    Microbiol Res; 2022 Aug; 261():127055. PubMed ID: 35597076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the nasopharyngeal microbiome and respiratory pathogens in COVID-19 patients from Saudi Arabia.
    Yasir M; Al-Sharif HA; Al-Subhi T; Sindi AA; Bokhary DH; El-Daly MM; Alosaimi B; Hamed ME; Karim AM; Hassan AM; AlShawdari MM; Alawi M; El-Kafrawy SA; Azhar EI
    J Infect Public Health; 2023 May; 16(5):680-688. PubMed ID: 36934642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome.
    Rosas-Salazar C; Kimura KS; Shilts MH; Strickland BA; Freeman MH; Wessinger BC; Gupta V; Brown HM; Rajagopala SV; Turner JH; Das SR
    J Allergy Clin Immunol; 2021 Apr; 147(4):1226-1233.e2. PubMed ID: 33577896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 does not have a strong effect on the nasopharyngeal microbial composition.
    Braun T; Halevi S; Hadar R; Efroni G; Glick Saar E; Keller N; Amir A; Amit S; Haberman Y
    Sci Rep; 2021 Apr; 11(1):8922. PubMed ID: 33903709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.